Lantern Pharma (LTRN) Non-Current Assets (2019 - 2026)
Lantern Pharma's Non-Current Assets was $143,430 in Q2 2026, down 34.7% from $219,502 a year earlier and down 13.5% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Lantern Pharma came in at $232,639, down 28.2% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $324,163 in FY2024 (+5.8%), $306,291 in FY2023 (+169.7%), $113,584 in FY2022 (-90.8%) and $1.23 million in FY2021 (+905.7%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2022.
- Compared with a year earlier, Non-Current Assets has declined for five straight quarters, with an average decline of 20.8% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2021 (growth of 905.7%); the worst was Q4 2022 (a decline of 90.8%).
- Per Business Quant data, LTRN's Non-Current Assets in the three quarters before Q2 2026 was $165,807 (Q1 2026), $232,639 (Q4 2025) and $165,805 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.40 Bn | 1,115.99 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 623.11 Bn | 541.63 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 509.31 Bn | 482.42 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 365.84 Bn | 320.22 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.62 Bn | 235.30 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.65 Bn | 191.05 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.97 Bn | 118.61 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Lantern Pharma | 8.62 Mn | -27.54 Mn | - | 143,430.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,430.00 |
| Mar 31, 2026 | 165,807.00 |
| Dec 31, 2025 | 232,639.00 |
| Sep 30, 2025 | 165,805.00 |
| Jun 30, 2025 | 219,502.00 |
| Mar 31, 2025 | 272,959.00 |
| Dec 31, 2024 | 324,163.00 |
| Sep 30, 2024 | 372,304.00 |
| Jun 30, 2024 | 295,352.00 |
| Mar 31, 2024 | 263,363.00 |
| Dec 31, 2023 | 306,291.00 |
| Sep 30, 2023 | 345,527.00 |
| Jun 30, 2023 | 384,074.00 |
| Mar 31, 2023 | 341,755.00 |
| Dec 31, 2022 | 113,584.00 |
| Sep 30, 2022 | 144,620.00 |
| Jun 30, 2022 | 716,818.00 |
| Mar 31, 2022 | 739,359.00 |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.27 Mn |
API Access
Lantern Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();